61 related articles for article (PubMed ID: 23422109)
1. Radiolabeling LyP-1 peptide and preliminary biodistribution evaluation in mice bearing MDA-MB-435 xenografts.
Yu MM; Wang RF; Chen YH; Zhou HZ; Deng XH
Chin Med J (Engl); 2013 Feb; 126(3):471-5. PubMed ID: 23422109
[TBL] [Abstract][Full Text] [Related]
2. Study on biodistribution and imaging of radioiodinated arginine-arginine-leucine peptide in nude mice bearing human prostate carcinoma.
Yu M; Zhou H; Liu X; Huo Y; Zhu Y; Chen Y
Ann Nucl Med; 2010 Jan; 24(1):13-9. PubMed ID: 19997991
[TBL] [Abstract][Full Text] [Related]
3. A tumor-homing peptide with a targeting specificity related to lymphatic vessels.
Laakkonen P; Porkka K; Hoffman JA; Ruoslahti E
Nat Med; 2002 Jul; 8(7):751-5. PubMed ID: 12053175
[TBL] [Abstract][Full Text] [Related]
4. LyP-1 Conjugated Nanoparticles for Magnetic Resonance Imaging of Triple Negative Breast Cancer.
Abulrob A; Corluka S; Blasiak B; Gino Fallone B; Ponjevic D; Matyas J; Tomanek B
Mol Imaging Biol; 2018 Jun; 20(3):428-435. PubMed ID: 29101636
[TBL] [Abstract][Full Text] [Related]
5. Tumor targeting of baculovirus displaying a lymphatic homing peptide.
Mäkelä AR; Enbäck J; Laakkonen JP; Vihinen-Ranta M; Laakkonen P; Oker-Blom C
J Gene Med; 2008 Sep; 10(9):1019-31. PubMed ID: 18655234
[TBL] [Abstract][Full Text] [Related]
6. LyP-1-conjugated doxorubicin-loaded liposomes suppress lymphatic metastasis by inhibiting lymph node metastases and destroying tumor lymphatics.
Yan Z; Zhan C; Wen Z; Feng L; Wang F; Liu Y; Yang X; Dong Q; Liu M; Lu W
Nanotechnology; 2011 Oct; 22(41):415103. PubMed ID: 21914940
[TBL] [Abstract][Full Text] [Related]
7. Study on biodistribution and radioimmunoimaging of (131)iodine-labeled monoclonal antibody D-D3 against progastrin-releasing peptide31-98 in tumor-bearing mouse.
Liu Z; Zhou X; Shi Y; Du S; Yang Y; Tang J; Shen Y
Cancer Biother Radiopharm; 2011 Apr; 26(2):229-35. PubMed ID: 21510749
[TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of bombesin peptide derivatives as potential tumor imaging agents: effects of structure and composition of amino acid sequence on in vitro and in vivo characteristics.
Okarvi SM; Jammaz IA
Nucl Med Biol; 2012 Aug; 39(6):795-804. PubMed ID: 22381782
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells.
Laakkonen P; Akerman ME; Biliran H; Yang M; Ferrer F; Karpanen T; Hoffman RM; Ruoslahti E
Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9381-6. PubMed ID: 15197262
[TBL] [Abstract][Full Text] [Related]
10. LyP-1-Modified Multifunctional Dendrimers for Targeted Antitumor and Antimetastasis Therapy.
Song N; Zhao L; Xu X; Zhu M; Liu C; Sun N; Yang J; Shi X; Zhao J
ACS Appl Mater Interfaces; 2020 Mar; 12(11):12395-12406. PubMed ID: 32077680
[TBL] [Abstract][Full Text] [Related]
11. LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors.
Luo G; Yu X; Jin C; Yang F; Fu D; Long J; Xu J; Zhan C; Lu W
Int J Pharm; 2010 Jan; 385(1-2):150-6. PubMed ID: 19825404
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
[TBL] [Abstract][Full Text] [Related]
13. Design, characterization and in vitro evaluation of SMEDDS containing an anticancer peptide, linear LyP-1.
Gürsoy RN; Çevik Ö
Pharm Dev Technol; 2014 Jun; 19(4):486-90. PubMed ID: 23678858
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG small-animal PET/CT differentiates trastuzumab-responsive from unresponsive human breast cancer xenografts in athymic mice.
McLarty K; Fasih A; Scollard DA; Done SJ; Vines DC; Green DE; Costantini DL; Reilly RM
J Nucl Med; 2009 Nov; 50(11):1848-56. PubMed ID: 19837760
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of the breast cancer cell-binding peptide, p160.
Askoxylakis V; Zitzmann S; Mier W; Graham K; Krämer S; von Wegner F; Fink RH; Schwab M; Eisenhut M; Haberkorn U
Clin Cancer Res; 2005 Sep; 11(18):6705-12. PubMed ID: 16166451
[TBL] [Abstract][Full Text] [Related]
16. LyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumor.
Yan Z; Wang F; Wen Z; Zhan C; Feng L; Liu Y; Wei X; Xie C; Lu W
J Control Release; 2012 Jan; 157(1):118-25. PubMed ID: 21827801
[TBL] [Abstract][Full Text] [Related]
17. Structure Reconstruction of LyP-1:
Zhang X; Wang F; Shen Q; Xie C; Liu Y; Pan J; Lu W
Mol Pharm; 2018 Feb; 15(2):430-436. PubMed ID: 29215294
[TBL] [Abstract][Full Text] [Related]
18.
Song N; Zhao L; Zhu M; Zhao J
Contrast Media Mol Imaging; 2019; 2019():9502712. PubMed ID: 31598115
[TBL] [Abstract][Full Text] [Related]
19. Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor α(v)β(3) expression.
Morales-Avila E; Ferro-Flores G; Ocampo-García BE; De León-Rodríguez LM; Santos-Cuevas CL; García-Becerra R; Medina LA; Gómez-Oliván L
Bioconjug Chem; 2011 May; 22(5):913-22. PubMed ID: 21513349
[TBL] [Abstract][Full Text] [Related]
20. [Establishment of a bioluminescent MDA-MB-231 cell line for in vivo imaging of human triple-negative breast cancer xenograft].
Wang K; Xie SM; He JJ; Ren Y; Xia HB; Zhang XW
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1812-8. PubMed ID: 22126756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
